SlideShare a Scribd company logo
1 of 28
Download to read offline
Ataur Rahman
Visual Inspection Aided with Acetic Acid (VIA):
A Feasible Approach for Cervical Cancer
Screening in Bangladesh
12th Annual Scientific Conference at ICDDR’B
Dhaka, Bangladesh
9-12 February 2009
Cervical Cancer: Magnitude of the Problem
• Cervical cancer is the third most common cancer
worldwide
• Globally 493,000 new cases identified each year
• 83% of the new cases occur in developing
countries
• India alone reported 132,000 new cases in 2002
• Globally at least 274,000 women die of cervical
cancer each year
sources: Ferlay J et al. Globocan 2002
Cervical Cancer: Bangladesh
• Leading cause of deaths of all cancer deaths among
women
• Population based studies on cervical cancer are rare
• Hospital data suggests that 25% of all cancer deaths
for women are due to cervical cancer
• No screening system available in present health
system
Incidence and mortality rate of ovarian cancer in
Finland, Bangladesh and Sri Lanka
Mortality rate of cancer cervix in Bangladesh, Sri
Lanka, Finland and UK
Normal cervix in naked eye
Natural History of Cervical Cancer: Current Understanding
Normal Cervix
HPV-related Changes
Low-Grade Lesion (mild dysplasia)
High-Grade Lesion (severe dysplasia)
Invasive Cancer
About 60%
regress within
2-3 yrs
HPV Infection
About 15% progress within 3-4 yrs
30% - 70% progress within 10 yrs
Source: PATH 1997
Limitations of Pap Smears for National Screening
Programs
• Pap smear-based programs require complex logistics,
advanced training, and well managed program
implementation for adequate testing to occur.
• These elements are not available outside large cities in
many low-resource settings.
• Even in large cities, quality Pap smears are possible but
ongoing supervision, refresher training and continued
supplies are not adequate.
• Cytology is not viable as a nationally accessible
screening method in many developing countries.
Other Cervical Cancer screening methods
• Visual Inspection aided with acetic acid (VIA)
• Visual Inspection with acetic acid and
magnification (VIAM)
• Cervicography
• Automated Pap smears
• Molecular (HPV/DNA) tests
• Colposcopy
Visual Inspection Aided with Acetic Acid
• Looking at the cervix to detect abnormalities after
applying acetic acid
• Acetic acid is used to enhance and “mark” the
acetowhite change of a precancerous lesion or actual
cancer
Equipment and material needed for VIA
VIA can be performed in any clinical setting where the
followings are available
• Adequate light source to look at the cervix and
examining its details
• Vaginal speculum, swabs and examination gloves
• Table permitting the examiner to insert the speculum
and view the cervix
• Freshly prepared acetic acid (3-5%, vinegar)
Visual Inspection aided with Acetic Acid
Aceto-white lesion with punctation: a pre-cancerous condition
Visual Inspection aided with Acetic-Acid
Aceto-white lesion with punctation: a pre-cancerous condition
Objectives of the study
To calculate the sensitivity, specificity and positive
predictive values of VIA and Pap smear using
colposcopy with biopsy as the reference test.
To evaluate women’s knowledge and attitude
towards cervical cancer and its prevention through
a screening test in study population.
Method and study locations
A cross-sectional population based study compared two
screening systems for cancer cervical
All ever married women attended in one Urban clinic and
resided in two rural locations (‘Modonpur’ and ‘Dhamgor’
Unions) were invited to perform VIA and Pap Smear tests
All VIA or Pap smear positive and every tenth VIA
negative women were sent to a tertiary level hospital for
reference test
Positive for Pap Smear
Low-grade intraepithelial lesion or more which correspond
CIN I to CIN III (including carcinoma in situ)
Abnormal finding which corresponds detection of one or
more of the following lesions:
Aceto-white lesion, White plaques, Ulcer, Cauliflower-like
growth, fungating mass
Outcome measures
Positive for VIA
 Reference test was
Colposcopy with biopsy (where indicated)
• Positive for reference test
- a low threshold of low-grade squamous intraepithelial
lesion (LGIL)
- a high threshold of high-grade squamous
intraepithelial lesion HGIL
Number of women participated in different stages
Women
- listed as eligible 8036
- Came to health centre for participation 3290
- Went for VIA screening 2954
- Went for Pap smear collection 2724
Women conducted reference test
As they were VIA positive 288
As they were VIA negative 366
As they Pap positive 10
Women conducted gold test 654
Sensitivity and Specificity of VIA
In detecting at least low-grade lesion
95% CI
Sensitivity 68.0% 59 – 76%
Specificity 61.0% 57 – 65%
In detecting high-grade lesion
Sensitivity 79.0% 63 – 90%
Specificity 57.4% 53 – 61%
Sensitivity and Specificity for Pap smear
In detecting at least low-grade lesion
95% CI
Sensitivity 2.0% 0.3 – 8.0%
Specificity 98.4 96.2– 99.6%
Findings from other studies on Pap Smear
• One meta-analysis, combined data from 59
studies of Pap smear estimated
Sensitivity 11 to 99%
Specificity 14 to 97%
• Pap test was unable to achieve concurrently high
sensitivity and specificity
• Specificity 90-95% correspond to sensitivity 20-
30%
(Fahey MT, 1995)
Inter-observer variation of VIA performance
Level
%
95% CI Background of paramedics
Paramedic 1
Sn
Sp
58.3
64.3
45 -71
57 -71
No formal training, worked as
nurse 10 yrs. in a clinic, used to
do PV
Paramedic 2
Sn
Sp
71.4
71.4
52 – 82
58 - 82
With 18 months formal
training, 7 yrs. working
experience, used to do PV
Paramedic 3
Sn
Sp
65.4
64.2
49 – 83
55 -73
Had 6 weeks training on Pap
Smear, worked 3 yrs. in a
diagnostic clinic, used to do PV
Colposcopy: Reference test
Sample collection for Pap smear using cervical spatula
Scraping cells from
cervix
Making Pap smear slide
Then smearing and
fixing on glass
Pap slide: under microscope
Evaluated by
trained cytologist

More Related Content

What's hot

HPV SCREENING & CO TESTING
HPV SCREENING & CO TESTINGHPV SCREENING & CO TESTING
HPV SCREENING & CO TESTINGNiranjan Chavan
 
Shoulder to Shoulder: Cervical Cancer Screening
Shoulder to Shoulder: Cervical Cancer ScreeningShoulder to Shoulder: Cervical Cancer Screening
Shoulder to Shoulder: Cervical Cancer Screeningshouldertoshoulder
 
Cervical cancer screening guidelines 2013
Cervical cancer screening guidelines 2013Cervical cancer screening guidelines 2013
Cervical cancer screening guidelines 2013Lifecare Centre
 
Hysteroscopy pre IVF is it neccessary ??
Hysteroscopy pre IVF is it neccessary ??Hysteroscopy pre IVF is it neccessary ??
Hysteroscopy pre IVF is it neccessary ??NARENDRA MALHOTRA
 
New Zealand Cervical Cancer Experiment
New Zealand Cervical Cancer ExperimentNew Zealand Cervical Cancer Experiment
New Zealand Cervical Cancer ExperimentRachel Walden
 
Briefing Note: Cervical Cancer Screening in the Gwassi Division, Suba Distric...
Briefing Note: Cervical Cancer Screening in the Gwassi Division, Suba Distric...Briefing Note: Cervical Cancer Screening in the Gwassi Division, Suba Distric...
Briefing Note: Cervical Cancer Screening in the Gwassi Division, Suba Distric...sarahsteklov
 
3- ca cx ppt final
 3- ca cx ppt final 3- ca cx ppt final
3- ca cx ppt finalBasalama Ali
 
Cervical Screening State of the Art 2016
Cervical Screening State of the Art 2016Cervical Screening State of the Art 2016
Cervical Screening State of the Art 2016Dr Dirk Grothuesmann
 
Chapter 2.4 cancer screening
Chapter 2.4 cancer screeningChapter 2.4 cancer screening
Chapter 2.4 cancer screeningNilesh Kucha
 
Cervical Cancer Screening Modalities
Cervical Cancer Screening ModalitiesCervical Cancer Screening Modalities
Cervical Cancer Screening ModalitiesDr. Rahul Shah
 
Karl Ulrich Petry - Performance standards
Karl Ulrich Petry - Performance standards    Karl Ulrich Petry - Performance standards
Karl Ulrich Petry - Performance standards triumphbenelux
 
See & treat prog dr. sharda jain
See & treat prog  dr. sharda jainSee & treat prog  dr. sharda jain
See & treat prog dr. sharda jainLifecare Centre
 
Colposcopic guidelines - a critique
Colposcopic guidelines - a critiqueColposcopic guidelines - a critique
Colposcopic guidelines - a critiquetriumphbenelux
 
Screening c cervix slideshare 2015 (1)
Screening c cervix   slideshare 2015 (1)Screening c cervix   slideshare 2015 (1)
Screening c cervix slideshare 2015 (1)Mohammad Emam
 
Prevention and screening in brca mutation carriers for breast cancers
Prevention and screening in brca mutation carriers for breast cancersPrevention and screening in brca mutation carriers for breast cancers
Prevention and screening in brca mutation carriers for breast cancersDr. Rahul Shah
 
Save uterus At Dehradoon by dr. Sharda Jain
Save uterus At Dehradoon by dr. Sharda Jain Save uterus At Dehradoon by dr. Sharda Jain
Save uterus At Dehradoon by dr. Sharda Jain Lifecare Centre
 
Breast Health and BreastScreen Victoria
Breast Health and BreastScreen VictoriaBreast Health and BreastScreen Victoria
Breast Health and BreastScreen VictoriaJohn Lee
 

What's hot (20)

HPV SCREENING & CO TESTING
HPV SCREENING & CO TESTINGHPV SCREENING & CO TESTING
HPV SCREENING & CO TESTING
 
Shoulder to Shoulder: Cervical Cancer Screening
Shoulder to Shoulder: Cervical Cancer ScreeningShoulder to Shoulder: Cervical Cancer Screening
Shoulder to Shoulder: Cervical Cancer Screening
 
Cervical cancer screening guidelines 2013
Cervical cancer screening guidelines 2013Cervical cancer screening guidelines 2013
Cervical cancer screening guidelines 2013
 
Cervical cancer screening
Cervical cancer screening Cervical cancer screening
Cervical cancer screening
 
Hysteroscopy pre IVF is it neccessary ??
Hysteroscopy pre IVF is it neccessary ??Hysteroscopy pre IVF is it neccessary ??
Hysteroscopy pre IVF is it neccessary ??
 
New Zealand Cervical Cancer Experiment
New Zealand Cervical Cancer ExperimentNew Zealand Cervical Cancer Experiment
New Zealand Cervical Cancer Experiment
 
Briefing Note: Cervical Cancer Screening in the Gwassi Division, Suba Distric...
Briefing Note: Cervical Cancer Screening in the Gwassi Division, Suba Distric...Briefing Note: Cervical Cancer Screening in the Gwassi Division, Suba Distric...
Briefing Note: Cervical Cancer Screening in the Gwassi Division, Suba Distric...
 
3- ca cx ppt final
 3- ca cx ppt final 3- ca cx ppt final
3- ca cx ppt final
 
Cervical Screening State of the Art 2016
Cervical Screening State of the Art 2016Cervical Screening State of the Art 2016
Cervical Screening State of the Art 2016
 
Cervical cancer screening and care
Cervical cancer screening and careCervical cancer screening and care
Cervical cancer screening and care
 
Chapter 2.4 cancer screening
Chapter 2.4 cancer screeningChapter 2.4 cancer screening
Chapter 2.4 cancer screening
 
Cervical Cancer Screening Modalities
Cervical Cancer Screening ModalitiesCervical Cancer Screening Modalities
Cervical Cancer Screening Modalities
 
Karl Ulrich Petry - Performance standards
Karl Ulrich Petry - Performance standards    Karl Ulrich Petry - Performance standards
Karl Ulrich Petry - Performance standards
 
See & treat prog dr. sharda jain
See & treat prog  dr. sharda jainSee & treat prog  dr. sharda jain
See & treat prog dr. sharda jain
 
Colposcopic guidelines - a critique
Colposcopic guidelines - a critiqueColposcopic guidelines - a critique
Colposcopic guidelines - a critique
 
Screening c cervix slideshare 2015 (1)
Screening c cervix   slideshare 2015 (1)Screening c cervix   slideshare 2015 (1)
Screening c cervix slideshare 2015 (1)
 
Prevention and screening in brca mutation carriers for breast cancers
Prevention and screening in brca mutation carriers for breast cancersPrevention and screening in brca mutation carriers for breast cancers
Prevention and screening in brca mutation carriers for breast cancers
 
Save uterus At Dehradoon by dr. Sharda Jain
Save uterus At Dehradoon by dr. Sharda Jain Save uterus At Dehradoon by dr. Sharda Jain
Save uterus At Dehradoon by dr. Sharda Jain
 
Cervical cancer
Cervical cancerCervical cancer
Cervical cancer
 
Breast Health and BreastScreen Victoria
Breast Health and BreastScreen VictoriaBreast Health and BreastScreen Victoria
Breast Health and BreastScreen Victoria
 

Viewers also liked

Il CdA Hera approva i risultati del terzo trimestre 2015
Il CdA Hera approva i risultati del terzo trimestre 2015Il CdA Hera approva i risultati del terzo trimestre 2015
Il CdA Hera approva i risultati del terzo trimestre 2015Hera Group
 
Chris collins dacula ga @Real Estate Tips
Chris collins dacula ga @Real Estate TipsChris collins dacula ga @Real Estate Tips
Chris collins dacula ga @Real Estate TipsChris Collins Dacula ga
 
Food customs among minority groups
Food customs among minority groups Food customs among minority groups
Food customs among minority groups agustinasanguinetti
 
Lean Solutions in NHS – Midland Forum
Lean Solutions in NHS – Midland ForumLean Solutions in NHS – Midland Forum
Lean Solutions in NHS – Midland ForumKinetik Solutions Ltd
 
SHAIK IRFAN VALI resume (solar)
SHAIK IRFAN VALI  resume (solar)SHAIK IRFAN VALI  resume (solar)
SHAIK IRFAN VALI resume (solar)Irfan Vali
 
FINAL SickKids Presentation (Inspire, Imagine, Innovation)
FINAL SickKids Presentation (Inspire, Imagine, Innovation)FINAL SickKids Presentation (Inspire, Imagine, Innovation)
FINAL SickKids Presentation (Inspire, Imagine, Innovation)Anat Leibel
 
Foetal development gihs
Foetal development   gihsFoetal development   gihs
Foetal development gihsgangahealth
 
Cloud complete
Cloud completeCloud complete
Cloud completeNavriti
 
Week Wise Pregnancy and Fetus Development
Week Wise Pregnancy and Fetus DevelopmentWeek Wise Pregnancy and Fetus Development
Week Wise Pregnancy and Fetus DevelopmentVirtue Baby
 
Infant Brain Development
Infant Brain DevelopmentInfant Brain Development
Infant Brain Developmentjvonschilling
 
Kalusugang Pankalusugan - Introduction and Thrust
Kalusugang Pankalusugan - Introduction and ThrustKalusugang Pankalusugan - Introduction and Thrust
Kalusugang Pankalusugan - Introduction and Thrustrhugamu
 

Viewers also liked (20)

Il CdA Hera approva i risultati del terzo trimestre 2015
Il CdA Hera approva i risultati del terzo trimestre 2015Il CdA Hera approva i risultati del terzo trimestre 2015
Il CdA Hera approva i risultati del terzo trimestre 2015
 
Chris collins dacula ga @Real Estate Tips
Chris collins dacula ga @Real Estate TipsChris collins dacula ga @Real Estate Tips
Chris collins dacula ga @Real Estate Tips
 
Food customs among minority groups
Food customs among minority groups Food customs among minority groups
Food customs among minority groups
 
PORTFOLI DAVID FONTANILS LLACH
PORTFOLI DAVID FONTANILS LLACHPORTFOLI DAVID FONTANILS LLACH
PORTFOLI DAVID FONTANILS LLACH
 
Botol
BotolBotol
Botol
 
5th Semester VTU BE EC question papers from 2010 to June 2016
5th Semester VTU BE EC question papers from 2010 to June 20165th Semester VTU BE EC question papers from 2010 to June 2016
5th Semester VTU BE EC question papers from 2010 to June 2016
 
Standard work in_services_final
Standard work in_services_finalStandard work in_services_final
Standard work in_services_final
 
Lean Solutions in NHS – Midland Forum
Lean Solutions in NHS – Midland ForumLean Solutions in NHS – Midland Forum
Lean Solutions in NHS – Midland Forum
 
SHAIK IRFAN VALI resume (solar)
SHAIK IRFAN VALI  resume (solar)SHAIK IRFAN VALI  resume (solar)
SHAIK IRFAN VALI resume (solar)
 
FINAL SickKids Presentation (Inspire, Imagine, Innovation)
FINAL SickKids Presentation (Inspire, Imagine, Innovation)FINAL SickKids Presentation (Inspire, Imagine, Innovation)
FINAL SickKids Presentation (Inspire, Imagine, Innovation)
 
ECCD Evaluation
ECCD EvaluationECCD Evaluation
ECCD Evaluation
 
Fetal Development
Fetal DevelopmentFetal Development
Fetal Development
 
Methods of cooking
Methods of cooking Methods of cooking
Methods of cooking
 
Growth and development full
Growth and development full Growth and development full
Growth and development full
 
Foetal development gihs
Foetal development   gihsFoetal development   gihs
Foetal development gihs
 
Cloud complete
Cloud completeCloud complete
Cloud complete
 
Week Wise Pregnancy and Fetus Development
Week Wise Pregnancy and Fetus DevelopmentWeek Wise Pregnancy and Fetus Development
Week Wise Pregnancy and Fetus Development
 
Infant Brain Development
Infant Brain DevelopmentInfant Brain Development
Infant Brain Development
 
Kalusugang Pankalusugan - Introduction and Thrust
Kalusugang Pankalusugan - Introduction and ThrustKalusugang Pankalusugan - Introduction and Thrust
Kalusugang Pankalusugan - Introduction and Thrust
 
Ppt sample
Ppt samplePpt sample
Ppt sample
 

Similar to cx_ca VIA presentation

Cervical screening , present past crown plaza final copy
Cervical screening , present past crown plaza  final copyCervical screening , present past crown plaza  final copy
Cervical screening , present past crown plaza final copyBasalama Ali
 
Cervical cancer screening guidelines 2013 on 7th sept
Cervical cancer screening guidelines 2013 on 7th septCervical cancer screening guidelines 2013 on 7th sept
Cervical cancer screening guidelines 2013 on 7th septLifecare Centre
 
Ovarian cancer screening
Ovarian cancer screening Ovarian cancer screening
Ovarian cancer screening Niranjan Chavan
 
HPV Infections, Cervical Dysplasia and the HPV Vaccine; What will the future ...
HPV Infections, Cervical Dysplasia and the HPV Vaccine; What will the future ...HPV Infections, Cervical Dysplasia and the HPV Vaccine; What will the future ...
HPV Infections, Cervical Dysplasia and the HPV Vaccine; What will the future ...Summit Health
 
Prevention of cancer in women
Prevention of cancer in women Prevention of cancer in women
Prevention of cancer in women vandana bansal
 
Cervical cancer by dr alka mukherjee dr apurva mukherjee nagpur m.s.
Cervical cancer by dr alka mukherjee dr apurva mukherjee nagpur m.s.Cervical cancer by dr alka mukherjee dr apurva mukherjee nagpur m.s.
Cervical cancer by dr alka mukherjee dr apurva mukherjee nagpur m.s.alka mukherjee
 
Cervicalcancer 180428125921-converted - copy final
Cervicalcancer 180428125921-converted - copy finalCervicalcancer 180428125921-converted - copy final
Cervicalcancer 180428125921-converted - copy finalmadurai
 
BSE and Mammography
BSE and MammographyBSE and Mammography
BSE and MammographyKawita Bapat
 
Cervical Cancer Prevention in Poor Resource areas : See & treatapproach dr. ...
Cervical Cancer Prevention in Poor Resource areas : See & treatapproach  dr. ...Cervical Cancer Prevention in Poor Resource areas : See & treatapproach  dr. ...
Cervical Cancer Prevention in Poor Resource areas : See & treatapproach dr. ...Lifecare Centre
 
1-uqu-presentation
 1-uqu-presentation 1-uqu-presentation
1-uqu-presentationBasalama Ali
 
Cervical cancer screening 14.02.24.....pptx
Cervical cancer screening 14.02.24.....pptxCervical cancer screening 14.02.24.....pptx
Cervical cancer screening 14.02.24.....pptxnaveenithkrishnan
 
Screening when where why
Screening when where why Screening when where why
Screening when where why Kawita Bapat
 
Presentation for public awareness
Presentation for public awarenessPresentation for public awareness
Presentation for public awarenessdrmcbansal
 
Presentation for public awareness
Presentation for public awareness Presentation for public awareness
Presentation for public awareness drmcbansal
 
Cervical cancer screening 14.02.24.....pptx
Cervical cancer screening 14.02.24.....pptxCervical cancer screening 14.02.24.....pptx
Cervical cancer screening 14.02.24.....pptxnaveenithkrishnan
 
Cervcal cancer prevention in sa
Cervcal cancer prevention in saCervcal cancer prevention in sa
Cervcal cancer prevention in saTariq Mohammed
 
Dr nisreen anfnan cervical cancer in saudi arabia last version
Dr nisreen anfnan cervical cancer in saudi arabia last versionDr nisreen anfnan cervical cancer in saudi arabia last version
Dr nisreen anfnan cervical cancer in saudi arabia last versionTariq Mohammed
 
screening_and_prevention protocols for_cervix.ppt
screening_and_prevention protocols for_cervix.pptscreening_and_prevention protocols for_cervix.ppt
screening_and_prevention protocols for_cervix.pptPriyankaSinha406376
 

Similar to cx_ca VIA presentation (20)

Cervical screening , present past crown plaza final copy
Cervical screening , present past crown plaza  final copyCervical screening , present past crown plaza  final copy
Cervical screening , present past crown plaza final copy
 
Cervical cancer screening guidelines 2013 on 7th sept
Cervical cancer screening guidelines 2013 on 7th septCervical cancer screening guidelines 2013 on 7th sept
Cervical cancer screening guidelines 2013 on 7th sept
 
Ovarian cancer screening
Ovarian cancer screening Ovarian cancer screening
Ovarian cancer screening
 
HPV Infections, Cervical Dysplasia and the HPV Vaccine; What will the future ...
HPV Infections, Cervical Dysplasia and the HPV Vaccine; What will the future ...HPV Infections, Cervical Dysplasia and the HPV Vaccine; What will the future ...
HPV Infections, Cervical Dysplasia and the HPV Vaccine; What will the future ...
 
Prevention of cancer in women
Prevention of cancer in women Prevention of cancer in women
Prevention of cancer in women
 
Cervical cancer by dr alka mukherjee dr apurva mukherjee nagpur m.s.
Cervical cancer by dr alka mukherjee dr apurva mukherjee nagpur m.s.Cervical cancer by dr alka mukherjee dr apurva mukherjee nagpur m.s.
Cervical cancer by dr alka mukherjee dr apurva mukherjee nagpur m.s.
 
Cervicalcancer 180428125921-converted - copy final
Cervicalcancer 180428125921-converted - copy finalCervicalcancer 180428125921-converted - copy final
Cervicalcancer 180428125921-converted - copy final
 
BSE and Mammography
BSE and MammographyBSE and Mammography
BSE and Mammography
 
Cervical Cancer Prevention in Poor Resource areas : See & treatapproach dr. ...
Cervical Cancer Prevention in Poor Resource areas : See & treatapproach  dr. ...Cervical Cancer Prevention in Poor Resource areas : See & treatapproach  dr. ...
Cervical Cancer Prevention in Poor Resource areas : See & treatapproach dr. ...
 
BSE and mammography
BSE and mammographyBSE and mammography
BSE and mammography
 
1-uqu-presentation
 1-uqu-presentation 1-uqu-presentation
1-uqu-presentation
 
Cervical cancer screening 14.02.24.....pptx
Cervical cancer screening 14.02.24.....pptxCervical cancer screening 14.02.24.....pptx
Cervical cancer screening 14.02.24.....pptx
 
Screening when where why
Screening when where why Screening when where why
Screening when where why
 
Presentation for public awareness
Presentation for public awarenessPresentation for public awareness
Presentation for public awareness
 
Presentation for public awareness
Presentation for public awareness Presentation for public awareness
Presentation for public awareness
 
Cervical cancer screening 14.02.24.....pptx
Cervical cancer screening 14.02.24.....pptxCervical cancer screening 14.02.24.....pptx
Cervical cancer screening 14.02.24.....pptx
 
Cervcal cancer prevention in sa
Cervcal cancer prevention in saCervcal cancer prevention in sa
Cervcal cancer prevention in sa
 
Ovarian Cancer Research and Prevention, Andrew Berchuck, MD
Ovarian Cancer Research and Prevention, Andrew Berchuck, MDOvarian Cancer Research and Prevention, Andrew Berchuck, MD
Ovarian Cancer Research and Prevention, Andrew Berchuck, MD
 
Dr nisreen anfnan cervical cancer in saudi arabia last version
Dr nisreen anfnan cervical cancer in saudi arabia last versionDr nisreen anfnan cervical cancer in saudi arabia last version
Dr nisreen anfnan cervical cancer in saudi arabia last version
 
screening_and_prevention protocols for_cervix.ppt
screening_and_prevention protocols for_cervix.pptscreening_and_prevention protocols for_cervix.ppt
screening_and_prevention protocols for_cervix.ppt
 

cx_ca VIA presentation

  • 1. Ataur Rahman Visual Inspection Aided with Acetic Acid (VIA): A Feasible Approach for Cervical Cancer Screening in Bangladesh 12th Annual Scientific Conference at ICDDR’B Dhaka, Bangladesh 9-12 February 2009
  • 2. Cervical Cancer: Magnitude of the Problem • Cervical cancer is the third most common cancer worldwide • Globally 493,000 new cases identified each year • 83% of the new cases occur in developing countries • India alone reported 132,000 new cases in 2002 • Globally at least 274,000 women die of cervical cancer each year sources: Ferlay J et al. Globocan 2002
  • 3. Cervical Cancer: Bangladesh • Leading cause of deaths of all cancer deaths among women • Population based studies on cervical cancer are rare • Hospital data suggests that 25% of all cancer deaths for women are due to cervical cancer • No screening system available in present health system
  • 4. Incidence and mortality rate of ovarian cancer in Finland, Bangladesh and Sri Lanka
  • 5. Mortality rate of cancer cervix in Bangladesh, Sri Lanka, Finland and UK
  • 6. Normal cervix in naked eye
  • 7. Natural History of Cervical Cancer: Current Understanding Normal Cervix HPV-related Changes Low-Grade Lesion (mild dysplasia) High-Grade Lesion (severe dysplasia) Invasive Cancer About 60% regress within 2-3 yrs HPV Infection About 15% progress within 3-4 yrs 30% - 70% progress within 10 yrs Source: PATH 1997
  • 8. Limitations of Pap Smears for National Screening Programs • Pap smear-based programs require complex logistics, advanced training, and well managed program implementation for adequate testing to occur. • These elements are not available outside large cities in many low-resource settings. • Even in large cities, quality Pap smears are possible but ongoing supervision, refresher training and continued supplies are not adequate. • Cytology is not viable as a nationally accessible screening method in many developing countries.
  • 9. Other Cervical Cancer screening methods • Visual Inspection aided with acetic acid (VIA) • Visual Inspection with acetic acid and magnification (VIAM) • Cervicography • Automated Pap smears • Molecular (HPV/DNA) tests • Colposcopy
  • 10. Visual Inspection Aided with Acetic Acid • Looking at the cervix to detect abnormalities after applying acetic acid • Acetic acid is used to enhance and “mark” the acetowhite change of a precancerous lesion or actual cancer
  • 11. Equipment and material needed for VIA VIA can be performed in any clinical setting where the followings are available • Adequate light source to look at the cervix and examining its details • Vaginal speculum, swabs and examination gloves • Table permitting the examiner to insert the speculum and view the cervix • Freshly prepared acetic acid (3-5%, vinegar)
  • 12. Visual Inspection aided with Acetic Acid Aceto-white lesion with punctation: a pre-cancerous condition
  • 13. Visual Inspection aided with Acetic-Acid Aceto-white lesion with punctation: a pre-cancerous condition
  • 14. Objectives of the study To calculate the sensitivity, specificity and positive predictive values of VIA and Pap smear using colposcopy with biopsy as the reference test. To evaluate women’s knowledge and attitude towards cervical cancer and its prevention through a screening test in study population.
  • 15. Method and study locations A cross-sectional population based study compared two screening systems for cancer cervical All ever married women attended in one Urban clinic and resided in two rural locations (‘Modonpur’ and ‘Dhamgor’ Unions) were invited to perform VIA and Pap Smear tests All VIA or Pap smear positive and every tenth VIA negative women were sent to a tertiary level hospital for reference test
  • 16. Positive for Pap Smear Low-grade intraepithelial lesion or more which correspond CIN I to CIN III (including carcinoma in situ) Abnormal finding which corresponds detection of one or more of the following lesions: Aceto-white lesion, White plaques, Ulcer, Cauliflower-like growth, fungating mass Outcome measures Positive for VIA
  • 17.  Reference test was Colposcopy with biopsy (where indicated) • Positive for reference test - a low threshold of low-grade squamous intraepithelial lesion (LGIL) - a high threshold of high-grade squamous intraepithelial lesion HGIL
  • 18. Number of women participated in different stages Women - listed as eligible 8036 - Came to health centre for participation 3290 - Went for VIA screening 2954 - Went for Pap smear collection 2724 Women conducted reference test As they were VIA positive 288 As they were VIA negative 366 As they Pap positive 10 Women conducted gold test 654
  • 19. Sensitivity and Specificity of VIA In detecting at least low-grade lesion 95% CI Sensitivity 68.0% 59 – 76% Specificity 61.0% 57 – 65% In detecting high-grade lesion Sensitivity 79.0% 63 – 90% Specificity 57.4% 53 – 61%
  • 20. Sensitivity and Specificity for Pap smear In detecting at least low-grade lesion 95% CI Sensitivity 2.0% 0.3 – 8.0% Specificity 98.4 96.2– 99.6%
  • 21. Findings from other studies on Pap Smear • One meta-analysis, combined data from 59 studies of Pap smear estimated Sensitivity 11 to 99% Specificity 14 to 97% • Pap test was unable to achieve concurrently high sensitivity and specificity • Specificity 90-95% correspond to sensitivity 20- 30% (Fahey MT, 1995)
  • 22. Inter-observer variation of VIA performance Level % 95% CI Background of paramedics Paramedic 1 Sn Sp 58.3 64.3 45 -71 57 -71 No formal training, worked as nurse 10 yrs. in a clinic, used to do PV Paramedic 2 Sn Sp 71.4 71.4 52 – 82 58 - 82 With 18 months formal training, 7 yrs. working experience, used to do PV Paramedic 3 Sn Sp 65.4 64.2 49 – 83 55 -73 Had 6 weeks training on Pap Smear, worked 3 yrs. in a diagnostic clinic, used to do PV
  • 24.
  • 25.
  • 26. Sample collection for Pap smear using cervical spatula Scraping cells from cervix
  • 27. Making Pap smear slide Then smearing and fixing on glass
  • 28. Pap slide: under microscope Evaluated by trained cytologist